Authors: Lisman, T Leebeek, FWG Mosnier, LO Bouma, BN Meijers, JCM Janssen, HLA Nieuwenhuis, HK De Groot, PG

Citation: T. Lisman et al., Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is notassociated with increased plasma fibrinolysis, GASTROENTY, 121(1), 2001, pp. 131-139

Authors: Frijns, CJM Derksen, RHWM De Groot, PG Algra, A Fijnheer, R

Citation: Cjm. Frijns et al., Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus, CLIN EXP IM, 125(1), 2001, pp. 149-154

Authors: Simmelink, MJA Horbach, DA Derksen, RHWM Meijers, JCM Bevers, EM Willems, GM De Groot, PG

Citation: Mja. Simmelink et al., Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces, BR J HAEM, 113(3), 2001, pp. 621-629

Authors: Derksen, RHWM De Groot, PG Nieuwenhuis, HK Christiaens, GCML

Citation: Rhwm. Derksen et al., Treatment of women with aPL in pregnancy - Reply, ANN RHEUM D, 60(7), 2001, pp. 718-718

Authors: Kleinveld, HA Andersson, NE Van Voorthuizen, H Den Hartog, J De Groot, PG

Citation: Ha. Kleinveld et al., Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzer, SC J CL INV, 59(5), 1999, pp. 335-341

Authors: van Zanten, GH Heijnen, HFG Wu, YP Schut-Hese, KM Slootweg, PJ De Groot, PG Sixma, JJ Nieuwland, R

Citation: Gh. Van Zanten et al., Distribution of GPIb on and in resting platelets - Response, BLOOD, 92(12), 1998, pp. 4877-4877